Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Azienda Ospedaliero-Universitaria, Turin

Charité - Campus Benjamin Franklin, Berlin

Roswell Park Cancer Streets, Buffalo

University of Pennsylvania, Philadelphia

Universitätsklinikum Schleswig-Holstein, Kiel

Ospedali Riuniti di Bergamo, Bergamo

Hospital 12 de Octubre, Madrid

Winship Cancer Institute of Emory University, Atlanta

Medizinische Hochschule Hannover, Hanover

CHU de Purpan, Toulouse

Hospital universitario de Salamanca, Salamanca

Azienda Ospedaliera di Verona, Verona

Hospital Universitario Virgen Del Rocio, Seville

Hôpital de l'hôtel Dieu, Nantes

Universitätsklinikum Münster, Münster

Barbara Ann Karmanos Cancer Institute, Detroit

CHU d'Angers, Angers

Mayo Clinic, Rochester

Klinikum der Goethe Universität, Medizinische Klinik II, Frankfurt

Rush University Medical Center, Chicago

University of Chicago, Chicago

Washington University School of Medicine, St Louis

Universitätsklinikum Tübingen, Tübingen

Hôpital Saint Louis, Paris

University of Texas MD Anderson Cancer Center, Houston

Universitätsklinikum Freiburg, Freiburg im Breisgau

Azienda Ospedaliera Antonio Cardarelli, Naples

Universitätsklinikum Ulm, Ulm

"Ospedali Riuniti Villa Sofia-Cervello", Palermo

Julius-Maximilians-Universität, Medizinische Klinik und Poliklinik II, Würzburg

City of Hope, Duarte

University of California Los Angeles, Los Angeles

Dana Farber Institute, Boston

Università La Sapienza di Roma, Rome

ICO Hospital Germans Trias I Pujol, Badalona

Hospital Clínic Servei d´Hematologia, Barcelona

University Hospitals Bristol NHS, Bristol

Royal Free Hampstead NHS Trust, London

The Christie NHS Foundation Trust, Manchester